BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21818089)

  • 21. Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes.
    Zhao Y; Tan M; Liu X; Xiong X; Sun Y
    Cell Death Dis; 2018 Feb; 9(2):145. PubMed ID: 29396424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
    Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
    Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
    Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
    Pan W; Issaq S; Zhang Y
    PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
    Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
    Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.
    Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R
    Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HEY1 functions are regulated by its phosphorylation at Ser-68.
    López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B
    Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ling Zhi-8 mediates p53-dependent growth arrest of lung cancer cells proliferation via the ribosomal protein S7-MDM2-p53 pathway.
    Wu CT; Lin TY; Hsu HY; Sheu F; Ho CM; Chen EI
    Carcinogenesis; 2011 Dec; 32(12):1890-6. PubMed ID: 21983128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.
    Uchi R; Kogo R; Kawahara K; Sudo T; Yokobori T; Eguchi H; Sugimachi K; Maehama T; Mori M; Suzuki A; Komune S; Mimori K
    Br J Cancer; 2013 Oct; 109(8):2199-206. PubMed ID: 24045667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and Mdm2: an auld alliance.
    Vigneron A; Vousden KH
    Cell Cycle; 2010 Mar; 9(5):865-6. PubMed ID: 20348845
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis in pluripotent stem cells: RPL11 strikes again.
    Donati G; Thomas G
    Cell Cycle; 2012 Mar; 11(5):840. PubMed ID: 22356748
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
    Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
    Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p53 Signalling Pathway in Cutaneous Basal Cell Carcinoma: An Immunohistochemical Description.
    Oh ST; Stark A; Reichrath J
    Acta Derm Venereol; 2020 Mar; 100(6):adv00098. PubMed ID: 32052850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
    Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
    Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.
    Llanos S; Serrano M
    Cell Cycle; 2010 Oct; 9(19):4005-12. PubMed ID: 20935493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
    Chen D; Zhang Z; Li M; Wang W; Li Y; Rayburn ER; Hill DL; Wang H; Zhang R
    Oncogene; 2007 Aug; 26(35):5029-37. PubMed ID: 17310983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
    Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
    J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.